GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » Debt-to-Asset

Biotech Growth Trust (The) (LSE:BIOG) Debt-to-Asset : 0.10 (As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Biotech Growth Trust (The) Debt-to-Asset?

Biotech Growth Trust (The)'s Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was £0.00 Mil. Biotech Growth Trust (The)'s Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was £39.02 Mil. Biotech Growth Trust (The)'s Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was £406.44 Mil. Biotech Growth Trust (The)'s debt to asset for the quarter that ended in Sep. 2024 was 0.10.


Biotech Growth Trust (The) Debt-to-Asset Historical Data

The historical data trend for Biotech Growth Trust (The)'s Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Growth Trust (The) Debt-to-Asset Chart

Biotech Growth Trust (The) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.04 0.07 0.06 0.11

Biotech Growth Trust (The) Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.04 0.11 0.10

Competitive Comparison of Biotech Growth Trust (The)'s Debt-to-Asset

For the Asset Management subindustry, Biotech Growth Trust (The)'s Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotech Growth Trust (The)'s Debt-to-Asset Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Biotech Growth Trust (The)'s Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Biotech Growth Trust (The)'s Debt-to-Asset falls into.


;
;

Biotech Growth Trust (The) Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Biotech Growth Trust (The)'s Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Biotech Growth Trust (The)'s Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotech Growth Trust (The)  (LSE:BIOG) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Biotech Growth Trust (The) Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Biotech Growth Trust (The)'s Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotech Growth Trust (The) Business Description

Traded in Other Exchanges
N/A
Address
25 Southampton Buildings, London, GBR, WC2A 1AL
Biotech Growth Trust (The) PLC is a United Kingdom-based investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world. Its performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

Biotech Growth Trust (The) Headlines

No Headlines